[{"words": [{"word": "本期", "head": 2, "tag": "r", "deprels": "ATT", "no": 0}, {"word": "业绩", "head": 3, "tag": "n", "deprels": "SBV", "no": 1}, {"word": "预增", "head": 6, "tag": "v", "deprels": "ATT", "no": 2}, {"word": "的", "head": 3, "tag": "u", "deprels": "RAD", "no": 3}, {"word": "主要", "head": 6, "tag": "b", "deprels": "ATT", "no": 4}, {"word": "原因", "head": 8, "tag": "n", "deprels": "FOB", "no": 5}, {"word": "本报", "head": 8, "tag": "r", "deprels": "SBV", "no": 6}, {"word": "告期", "head": 0, "tag": "v", "deprels": "HED", "no": 7}, {"word": "，", "head": 8, "tag": "wp", "deprels": "WP", "no": 8}, {"word": "公司", "head": 11, "tag": "n", "deprels": "SBV", "no": 9}, {"word": "控股", "head": 16, "tag": "v", "deprels": "ATT", "no": 10}, {"word": "子公司", "head": 11, "tag": "n", "deprels": "VOB", "no": 11}, {"word": "河南", "head": 14, "tag": "ns", "deprels": "ATT", "no": 12}, {"word": "辅仁堂", "head": 16, "tag": "nz", "deprels": "ATT", "no": 13}, {"word": "制药", "head": 16, "tag": "v", "deprels": "ATT", "no": 14}, {"word": "有限公司", "head": 18, "tag": "n", "deprels": "ATT", "no": 15}, {"word": "主营业务", "head": 18, "tag": "n", "deprels": "ATT", "no": 16}, {"word": "收入", "head": 21, "tag": "n", "deprels": "SBV", "no": 17}, {"word": "较", "head": 21, "tag": "p", "deprels": "ADV", "no": 18}, {"word": "上年", "head": 19, "tag": "nt", "deprels": "POB", "no": 19}, {"word": "增长", "head": 8, "tag": "v", "deprels": "COO", "no": 20}], "sentence": "本期业绩预增的主要原因本报告期，公司控股子公司河南辅仁堂制药有限公司主营业务收入较上年增长"}]